| Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients. | |
| Sophia Stock; Rudolf Übelhart; Maria-Luisa Schubert; Fuli Fan; Bailin He; Jean-Marc Hoffmann; Lei Wang; Sanmei Wang; Wenjie Gong; Brigitte Neuber | |
| 刊名 | International journal of cancer
 |
| 2019 | |
| 关键词 | Phosphatidylinositol 3-kinase (PI3K) chimeric antigen receptor (CAR) chronic lymphocytic leukemia idelalisib immunotherapy |
| ISSN号 | 1097-0215 |
| URL标识 | 查看原文 |
| 公开日期 | [db:dc_date_available] |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4617594 |
| 专题 | 湖南大学 |
| 作者单位 | Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany. Department of Medical Oncology, National Center for Tumor Diseases , Heidelberg University Hospital, Heidelberg, Germany. German Cancer Research Center , Heidelberg, Germany. German Cancer Consortium , Heidelberg, Germany. |
| 推荐引用方式 GB/T 7714 | Sophia Stock,Rudolf Übelhart,Maria-Luisa Schubert,et al. Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients.[J]. International journal of cancer,2019. |
| APA | Sophia Stock.,Rudolf Übelhart.,Maria-Luisa Schubert.,Fuli Fan.,Bailin He.,...&Leopold Sellner.(2019).Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients..International journal of cancer. |
| MLA | Sophia Stock,et al."Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients.".International journal of cancer (2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论